Showing results (151-160 of 306) with videos related to
Sort By:
Pageof 31
Virus Genes|March 31, 2019
A novel phage from periodontal pockets associated with chronic periodontitisYu Zhang, Tong-Ling Shan, Fei Li, et al.Dalton Transactions (Cambridge, England : 2003)|December 24, 2015
DNA-templated microwave-hydrothermal synthesis of nanostructured hydroxyapatite for storing and sustained release of an antibacterial proteinXi Chen, Bin Yang, Chao Qi, et al.The Chinese Journal of Dental Research|July 5, 2021
Prevalence and Associated Factors of Tooth Wear in ShanghaiTian Yu, Dan Ying Tao, Hai Xia Lu, et al.Shanghai Kou Qiang Yi Xue = Shanghai Journal of Stomatology|March 20, 2010
[Bilingual teaching in stomatological education in China: problems and future strategies]Jia-Wei Zheng, Xia Cao, Yuan-Jin Xu, et al.Cancer Journal (Sudbury, Mass.)|June 8, 2015
Prevalence of Human Papillomavirus in Oropharyngeal Cancer: A Systematic ReviewAndrew P Stein, Sandeep Saha, Jennifer L Kraninger, et al.Leukemia Research|May 11, 2011
Genetic disruption of the scaffolding protein, Kinase Suppressor of Ras 1 (KSR1), differentially regulates GM-CSF-stimulated hyperproliferation in hematopoietic progenitors expressing activating PTPN11 mutants D61Y and E76KZhenyun Yang, Mia Chen, Sarah A Sitarski, et al.Cancer Treatment Reviews|June 2, 2012
Treatment-related mortality with vascular endothelial growth factor receptor tyrosine kinase inhibitor therapy in patients with advanced solid tumors: a meta-analysisShanthi Sivendran, Ziyue Liu, Louis J Portas, et al.CA: a Cancer Journal for Clinicians|January 29, 2013
Risk factors, pathophysiology, and treatment of hot flashes in cancerWilliam I Fisher, Aimee K Johnson, Gary R Elkins, et al.Breast Cancer Research and Treatment|June 5, 2025
Phase I/II trial investigating gedatolisib plus talazoparib in advanced triple negative or BRCA1/2 positive, HER2 negative breast cancersSneha Phadke, Kathy D Miller, Ami Shah, et al.Cancer Letters|March 24, 2009
NF-kappaB inhibition in human hepatocellular carcinoma and its potential as adjunct to sorafenib based therapyJian-Min Wu, Hongmiao Sheng, Romil Saxena, et al.Pageof 31